Site performance diagnostics
Trace a stalled study from feasibility through enrollment and identify the operational constraints behind the numbers.
Explore site performance diagnostics →Cadence works with oncology and complex research teams to strengthen the work between protocol and patient: feasibility, study start-up, enrollment, quality, workflow, and day-to-day site operations.
Atlanta-based senior site-side support. Available for remote and on-site engagements across Georgia and the Southeast. Learn about our regional reach.
A sound protocol can still underperform at the site.
Activation drifts. A handoff between clinic and research goes quiet. Monitoring actions remain open. Coordinators work around a process instead of through it. Eligible participants never reach consent.
We start with the team and the evidence already available: how the work actually moves, where it waits, what the data shows, and which change is most likely to improve execution without adding unnecessary complexity.
Engagements are scoped around a defined operational problem rather than a broad transformation program. Start with one study, one workflow, or one portfolio constraint.
Trace a stalled study from feasibility through enrollment and identify the operational constraints behind the numbers.
Explore site performance diagnostics →Strengthen feasibility, start-up ownership, regulatory handoffs, budget and contract coordination, and activation workflow.
See start-up and activation support →Map identification, prescreening, eligibility, approach, consent, and follow-through so loss points become visible and actionable.
Review enrollment pathway consulting →Review monitoring follow-up, CAPA closure, eTMF organization, delegation controls, and site documentation habits before they become findings.
Explore quality and inspection readiness →Low patient enrollment is a symptom. The useful question is where participants are being lost: identification, prescreening, eligibility, approach, consent, or scheduling.
Cadence helps teams instrument the pathway, isolate the constraint, and focus effort where it can change performance. See our guide to why GU clinical trials stall at screening.
The shape is conceptual, not a performance benchmark. Actual analysis uses the site's own study data.
Cadence is intentionally site-centered. We work best where leaders want experienced operational perspective, candid collaboration, and changes the research team can sustain.
Portfolio, activation, enrollment, and site-quality problems across oncology and complex research programs.
Workflow redesign, team operating rhythm, inspection readiness, and study execution.
A structured operational review when a study is open but not moving as expected.
Site-side perspective on feasibility, activation, monitoring follow-up, and operational friction.
Cadence's clinical strategy is led by Sierra Williams Thomson, a research leader with fifteen years in research, including nine years concentrated in oncology and genitourinary clinical trials.
Practical guidance on enrollment, feasibility, study start-up, monitoring follow-up, CAPA, quality, and the workflow between a protocol and an enrolled participant.
We will start with the evidence, listen to the people closest to the work, define the operating problem, and tell you candidly whether Cadence is the right fit to help.